Literature DB >> 1093339

Some immunological aspects of liver function.

D R Triger.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1093339      PMCID: PMC2595197     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


× No keyword cloud information.
  26 in total

1.  Comparative response of normal and cirrhotic rats to intravenously injected bacteria.

Authors:  A M RUTENBURG; E SONNENBLICK; I KOVEN; F SCHWEINBURG; J FINE
Journal:  Proc Soc Exp Biol Med       Date:  1959-06

2.  RELATIONSHIP BETWEEN GAMMA-GLOBULIN METABOLISM AND LOW SERUM GAMMA-GLOBULIN IN GERMFREE MICE.

Authors:  S SELL; J L FAHEY
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

Review 3.  ASPECTS OF THE PATHOGENESIS OF VIRUS DISEASES.

Authors:  C A MIMS
Journal:  Bacteriol Rev       Date:  1964-03

4.  Influence of various disease states upon the febrile response to intravenous injection of typhoid bacterial pyrogen; with particular reference to malaria and cirrhosis of the liver.

Authors:  A HEYMAN; P B BEESON
Journal:  J Lab Clin Med       Date:  1949-10

5.  Viral antibodies and autoantibodies in chronic liver disease.

Authors:  D R Triger; J B Kurtz; R Wright
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

6.  Myxovirus antibody increases in human connective tissue disease.

Authors:  P E Phillips; C L Christian
Journal:  Science       Date:  1970-05-22       Impact factor: 47.728

7.  Antibodies to adenovirus in patients with infectious hepatitis.

Authors:  J Alwen
Journal:  Lancet       Date:  1973-06-23       Impact factor: 79.321

8.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

9.  Anti-Salmonella agglutinins in chronic active liver disease.

Authors:  R L Protell; R D Soloway; W J Martin; L J Schoenfield; W H Summerskill
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

10.  The half-life of I131 labeled normal human gamma globulin in patients with hepatic cirrhosis.

Authors:  W P HAVENS; J DICKENSHEETS; J N BIERLY; T P EBERHARD
Journal:  J Immunol       Date:  1954-10       Impact factor: 5.422

View more
  4 in total

1.  In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease.

Authors:  J R Wands; J L Dienstag; J R Weake; R S Koff
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

2.  Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure, and E. coli antibodies.

Authors:  D R Triger; T D Boyer; A G Redeker; T B Reynolds; A D Waxman
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

3.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

4.  Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.

Authors:  G Pomier-Layrargues; P M Huet; G Richer; D Marleau; A Viallet
Journal:  Dig Dis Sci       Date:  1980-07       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.